Suresh S. Ramalingam, MD

Executive director, Winship Cancer Institute of Emory University; Associate vice president for cancer, Woodruff Health Sciences Center; Roberto C. Goizueta Distinguished Chair for Cancer Research; Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine; Editor-in-chief, Cancer; Chair, 23rd Cancer Center Summit

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States.

April 25, 2025

Vol.51 No.16

By Suresh S. Ramalingam and Adam Marcus

Cancer History Project Guest Editorial

Discovery of EGFR mutations dramatically changed lung cancer treatment
20th anniversary of landmark findings

When I started fellowship training in the year 2000, the response from everyone when I mentioned my interest in lung cancer was nearly the same: “Are you sure?”

May 31, 2024

Vol.50 No.22

By Suresh S. Ramalingam

Suresh S. Ramalingam, MD

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Discovery of EGFR mutations dramatically changed lung cancer treatment
20th anniversary of landmark findings

Renew today!

Subscriber content

Never miss an issue!

Login

Suresh S. Ramalingam, MD

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Discovery of EGFR mutations dramatically changed lung cancer treatment20th anniversary of landmark findings

Never miss an issue!

Login

Discovery of EGFR mutations dramatically changed lung cancer treatment
20th anniversary of landmark findings